Rapport Therapeutics, Inc. (RAPP)
32.38
-1.20
(-3.57%)
USD |
NASDAQ |
Apr 06, 16:00
32.41
+0.03
(+0.09%)
After-Hours: 20:00
Rapport Therapeutics EPS Diluted (Quarterly) : -0.7187 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EyePoint Plc | -0.8143 |
| Praxis Precision Medicines, Inc. | -3.500 |
| Bridgebio Oncology Therapeutics, Inc. | -0.485 |
| Olema Pharmaceuticals, Inc. | -0.5044 |
| Arcellx, Inc. | -1.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.76M |
| Total Expenses (Quarterly) | 33.76M |
| Enterprise Value | 1.068B |
| Earnings Yield | -9.17% |
| Normalized Earnings Yield | -9.168 |